By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vernalis PLC (Formerly Known As British Biotech PLC) 

Watlington Road

Oxford    OX4 5LY  United Kingdom
Phone: 01865-748747 Fax: 01865-781047



ChemGenex Pharmaceuticals Limited  Discovery and development collaboration in anxiety and depression.

Company News
Vernalis PLC (VNLPY.PK) Announces Corvus Pharma As Its Worldwide Licensee For Their Adenosine Antagonist Program 1/6/2016 9:39:50 AM
Vernalis PLC (VNLPY.PK) Announces Successful Completion Of CCP-07 Pivotal Single-Dose Comparative Bioavailability Study 12/21/2015 11:03:54 AM
Vernalis PLC (VNLPY.PK) AGM Statement 12/2/2015 10:51:36 AM
Vernalis PLC (VNLPY.PK) Announces Start Of CCP-08 12 Month Stability Testing 10/12/2015 8:58:28 AM
Vernalis PLC (VNLPY.PK): Results Announcement For The 18 Months Ended 30 June 2015 9/29/2015 9:26:01 AM
Vernalis PLC (VNLPY.PK) Completes Investment In Its NCE Development Pipeline 8/20/2015 9:35:08 AM
Vernalis PLC (VNLPY.PK) Release: Appointment Of Non-Executive Director 8/18/2015 11:39:18 AM
Vernalis PLC (VNLPY.PK) - Appointment Of Non-Executive Director 6/30/2015 10:18:58 AM
Vernalis PLC (VNLPY.PK) Announces CCP-07 Starts 12 Month Stability Testing 6/11/2015 11:10:21 AM
Vernalis PLC (VNLPY.PK) And Tris Pharma, Inc. Receive FDA Approval Of NDA For Tuzistra XR (Codeine Polistirex And Chlorpheniramine Polistirex) 5/1/2015 7:49:52 AM